超募资金使用
Search documents
龙迅股份拟使用2150万元超募资金永久补充流动资金 占超募总额29.72%
Xin Lang Cai Jing· 2025-11-21 15:57
龙迅半导体(合肥)股份有限公司(以下简称"龙迅股份"或"公司")11月22日发布公告,拟使用2150万元 超募资金永久补充流动资金,该金额占公司超募资金总额的29.72%。公告显示,本次事项已通过董事 会及监事会审议,尚需提交公司股东大会审议。 募集资金基本情况 超募资金使用安排 公告显示,公司超募资金总额为7233.03万元。截至本次公告披露日,公司前次已累计使用4300万元超 募资金永久补充流动资金,本次拟再使用2150万元,本次使用金额占超募资金总额的29.72%。本次使 用后,公司累计使用超募资金永久补充流动资金金额将达6450万元。 公司表示,本次使用超募资金永久补充流动资金是在保证募集资金投资项目建设资金需求和正常进行的 前提下,为满足公司主营业务流动资金需求,旨在提高募集资金使用效率,降低财务成本,进一步提升 盈利能力。 公司承诺与合规性 公司明确承诺,每12个月内累计使用超募资金永久补充流动资金或归还银行贷款的金额不超过超募资金 总额的30%,本次29.72%的使用比例符合上述规定。同时,公司承诺在补充流动资金后的12个月内不进 行高风险投资,以及不为除控股子公司外的对象提供财务资助。 审议程 ...
豪恩汽电拟斥2000万元超募资金加码研发中心建设 两募投项目同步延期
Xin Lang Cai Jing· 2025-10-21 11:03
Core Points - The company, Shenzhen Haon Automotive Electronics Equipment Co., Ltd., held its 19th meeting of the third board of directors on October 21, 2025, where several important resolutions were passed, including the review of the Q3 2025 report and adjustments to fundraising projects [1][2] Group 1: Q3 2025 Report - The board approved the Q3 2025 report, which accurately reflects the company's operational status without any false statements or significant omissions [2] Group 2: Fundraising and Project Adjustments - The board agreed to allocate an additional 20 million yuan of over-raised funds to the "R&D Center Construction Project" and adjusted the internal investment structure of this project [3] - The company decided to postpone the "R&D Center Construction Project" and the "Enterprise Informationization Construction Project" based on actual development needs to enhance the efficiency of fund usage [3] Group 3: Upcoming Shareholder Meeting - A temporary shareholder meeting is scheduled for November 6, 2025, to vote on the resolutions that require shareholder approval [4] - All resolutions passed in the board meeting received unanimous support, with 6 votes in favor and no abstentions or oppositions [4]
隆达股份: 2025年第二次临时股东大会会议资料
Zheng Quan Zhi Xing· 2025-09-01 16:10
Core Viewpoint - Jiangsu Longda Superalloy Co., Ltd. is convening its second extraordinary general meeting of shareholders in 2025 to discuss key proposals, including the use of excess raised funds for operational liquidity and loan repayment, the registration of targeted debt financing tools, and a related leasing agreement to enhance employee accommodation [1][12][15]. Group 1: Use of Excess Funds - The company plans to use part of the excess raised funds, amounting to 80 million RMB, to permanently supplement working capital and repay bank loans, which constitutes 6.66% of the total excess funds of 1.2 billion RMB [8][9]. - The total raised funds from the initial public offering amounted to approximately 2.4 billion RMB, with a net amount of 2.2 billion RMB after deducting issuance costs [5][9]. - The company commits that the cumulative use of excess funds for working capital and loan repayment will not exceed 30% of the total excess funds within any 12-month period [8][9]. Group 2: Registration of Debt Financing Tools - The company intends to apply for the registration of targeted debt financing tools with a total amount not exceeding 1 billion RMB, which will be used for operational activities, including project construction and R&D [12][14]. - The proposed debt financing tools will have a term of up to 5 years, with interest rates determined based on the company's credit rating and market conditions [12][14]. - The issuance of these financing tools is subject to approval from the interbank market association and will enhance the company's financial structure and liquidity management [12][15]. Group 3: Leasing Agreement - The company plans to sign a leasing agreement with Wuxi Yuyuan Industrial Group for a property of 5,643.52 square meters to improve employee accommodation, with a total rental cost of approximately 9.83 million RMB over five years [15][20]. - This leasing transaction is classified as a related party transaction due to common control, but it does not constitute a major asset restructuring [16][22]. - The rental price is based on a real estate rental consulting report and is deemed fair and reasonable, ensuring no harm to the interests of the company and its shareholders [19][22].
澳华内镜: 中信证券股份有限公司关于上海澳华内镜股份有限公司使用部分超募资金永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-29 17:34
Summary of Key Points Core Viewpoint - The company intends to use part of the excess raised funds to permanently supplement its working capital, which is deemed beneficial for improving fund utilization efficiency and reducing financial costs [1][4]. Group 1: Fundraising Overview - The company was approved to issue 33.34 million shares at a price of RMB 22.50 per share, raising a total of RMB 750.15 million, with actual received funds amounting to RMB 691.40 million after deducting issuance costs [1]. - The total amount of excess raised funds is RMB 19.18 million, with the proposed amount for permanent working capital supplementation being RMB 5.75 million, accounting for 29.98% of the total excess funds [3][4]. Group 2: Fund Usage Plan - The company plans to use the excess funds to meet working capital needs while ensuring that the investment projects funded by the raised capital continue as planned [2][4]. - The company commits that the use of excess funds will not affect the funding needs of the investment projects and will only be used for operations related to its main business [4]. Group 3: Compliance and Approval Process - The proposal to use part of the excess funds was approved by the company's board of directors and supervisory board, and it will be submitted for shareholder approval [4][5]. - The sponsor institution has verified that the proposal complies with relevant regulations and is in the best interest of the company and its shareholders [5].
澳华内镜: 关于使用部分超募资金永久补充流动资金的公告
Zheng Quan Zhi Xing· 2025-08-29 17:25
Core Viewpoint - The company plans to use RMB 5.75 million of its excess raised funds to permanently supplement its working capital, which accounts for 29.98% of the total excess funds raised [1][2][5]. Fundraising Overview - The company was approved to issue 33.34 million shares at a price of RMB 22.50 per share, raising a total of RMB 750.15 million. After deducting issuance costs of RMB 90.97 million, the net amount raised was RMB 659.18 million [2][6]. - The total amount of excess funds raised is RMB 19.18 million [5][6]. Use of Excess Funds - The company commits to using the excess funds solely for operations related to its main business and will not affect the funding needs of the investment projects. The company will not engage in high-risk investments or provide financial assistance to entities outside its controlling subsidiaries within 12 months after the use of these funds [1][7]. - The cumulative amount used for permanent working capital and bank loan repayment within any 12-month period will not exceed 30% of the total excess funds raised [5][7]. Approval Process - The proposal to use part of the excess funds was approved by the company's board of directors and supervisory board, and it is pending approval from the shareholders' meeting [8][9]. - The supervisory board believes that using part of the excess funds for working capital will enhance the efficiency of fund usage and reduce financial costs, aligning with the interests of the company and all shareholders [8].
航材股份: 中信证券股份有限公司关于北京航空材料研究院股份有限公司使用超募资金收购股权暨关联交易的核查意见
Zheng Quan Zhi Xing· 2025-08-29 17:03
Fundraising Overview - The company has successfully completed an initial public offering (IPO) on the Sci-Tech Innovation Board, raising a total of RMB 710.91 million by issuing 90 million shares at a price of RMB 78.99 each [1][3] - After deducting various fees, the net proceeds from the fundraising amount to RMB 689.56 million, with RMB 362.22 million allocated for specific investment projects and RMB 327.34 million classified as excess funds [3][4] Investment Projects - The net proceeds from the IPO will be used for three main projects: 1. High-performance elastomer materials and components for aviation 2. High-temperature alloy products for aircraft engines and gas turbines 3. Upgrading heat treatment and precision processing technology for aerospace titanium alloy components [3][4] Use of Excess Funds - The company plans to use RMB 98 million of the excess funds to permanently supplement working capital and RMB 18.41 million to acquire intellectual property rights related to high-temperature alloys from its controlling shareholder [4][5] Transaction Details - The company intends to acquire 100% of the equity of Zhenjiang Titanium Alloy Company, which is currently partially owned by its controlling shareholder, China Aviation Materials Research Institute [5][10] - The acquisition price is set at RMB 54.01 million, based on an asset appraisal that indicates an 88.08% increase in the value of the equity compared to its book value [9][10] Financial Performance of Target Company - Zhenjiang Titanium Alloy Company reported revenues of RMB 15.20 million and a total profit of RMB 884.11 million for the year ending March 2025, with total assets amounting to RMB 63.43 million [7][8] Rationale for Acquisition - The acquisition is deemed necessary to enhance the company's production capacity in the titanium alloy precision casting business, which is one of its four major business segments [10][11] - The transaction aligns with commitments made during the IPO to avoid competition with the controlling shareholder and will integrate Zhenjiang Titanium Alloy Company into the company's consolidated financial statements [10][11] Approval Process - The transaction has been approved by the company's board of directors and supervisory board, and it will be submitted for approval at the upcoming shareholders' meeting [12][14] - The transaction is also subject to approval from the relevant state-owned asset authorities [13][14]
锴威特: 华泰联合证券有限责任公司关于苏州锴威特半导体股份有限公司使用部分超募资金永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-29 11:44
Core Viewpoint - The company plans to use part of the excess raised funds to permanently supplement its working capital, which is deemed necessary for its operational needs and aligns with the interests of the company and its shareholders [5][8]. Fundraising Overview - The company was approved to publicly issue 18,421,053 shares at a price of RMB 40.83 per share, raising a total of RMB 752.1316 million. After deducting issuance costs of RMB 87.3327 million, the net amount raised is RMB 664.7989 million, which has been fully received [1][2]. Fund Management - To ensure proper management and usage of the raised funds, the company has established a dedicated account for the funds, and a tripartite supervision agreement has been signed with the sponsor and the commercial bank [2]. Investment Project Details - The total investment amount for the projects disclosed in the prospectus is RMB 530.0828 million, with the same amount planned to be funded by the raised capital [3]. Previous Use of Excess Funds - The company has previously approved the use of RMB 40 million of excess funds to permanently supplement working capital and has also initiated a share buyback plan using excess funds, with a total buyback amount between RMB 10 million and RMB 20 million [4][6]. Current Plan for Excess Funds - The company intends to use RMB 40 million of excess funds to permanently supplement working capital, which represents 29.69% of the total excess funds. The cumulative use of excess funds in the last 12 months does not exceed 30% of the total excess funds [5][7]. Impact and Commitments - The use of excess funds for working capital will not affect the normal progress of investment projects and aims to enhance the efficiency of fund usage and reduce financial costs [5][8]. Review Procedures - The board of directors and the audit committee have approved the proposal to use excess funds for working capital, which will be submitted for shareholder approval [6][7]. Sponsor's Verification - The sponsor has verified that the use of excess funds for working capital will not alter the intended use of the raised funds or harm shareholder interests, and it complies with relevant regulations [8].
北京航空材料研究院股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-29 02:44
Group 1 - The company plans to distribute a cash dividend of RMB 2.3045 per 10 shares (including tax), totaling RMB 103,702,500, which accounts for 37.01% of the net profit attributable to ordinary shareholders for the first half of 2025 [4][5][6] - The total share capital as of June 30, 2025, is 450,000,000 shares, and the remaining undistributed profits will be carried forward to future years without issuing bonus shares or converting capital reserves into share capital [5][6] - The profit distribution plan requires approval from the shareholders' meeting [6] Group 2 - The company intends to use excess raised funds amounting to RMB 54,011.48 million to acquire 77% of the equity in Zhenjiang Titanium Alloy Precision Forming Co., Ltd. from its controlling shareholder [14][26] - This acquisition is part of the company's strategy to avoid competition with its controlling shareholder and enhance its titanium alloy precision casting business [14][27] - The transaction has been approved by the company's board and supervisory board, but it still requires approval from the shareholders' meeting and relevant government authorities [33][38] Group 3 - The company raised a total of RMB 710,910.00 million from its initial public offering, with a net amount of RMB 689,563.39 million after deducting related expenses [15][71] - As of June 30, 2025, the company has used RMB 229,776.13 million of the raised funds for investment projects, leaving a balance of RMB 459,787.26 million [72] - The company has established a special account for the management of raised funds, ensuring strict compliance with regulations regarding the use of these funds [73][74]
普瑞眼科:使用超募资金2282万元新建成都锦江普瑞眼科医院
Xin Lang Cai Jing· 2025-08-28 08:09
Core Viewpoint - The company has approved the use of part of the raised funds from its initial public offering to establish a new eye hospital in Chengdu, indicating a strategic expansion in the healthcare sector [1] Group 1: Project Details - The company will invest a total of RMB 22.82 million from the raised funds for the Chengdu Jinjiang Puri Eye Hospital project [1] - The total investment for the project is RMB 52.87 million, with the raised funds covering a significant portion [1] - The project will be implemented by Chengdu Jinjiang Puri Eye Hospital Co., Ltd., a wholly-owned subsidiary of the company [1] Group 2: Financial and Operational Aspects - The construction period for the project is estimated to be 11 months [1] - The company expects to recover the investment cost by the eighth year of operation [1]
华曙高科: 西部证券股份有限公司关于湖南华曙高科技股份有限公司使用部分超募资金永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-27 16:41
Core Viewpoint - The company, Hunan Huashu High-Tech Co., Ltd., plans to use part of the excess raised funds to permanently supplement its working capital, ensuring that the investment projects funded by the raised capital remain unaffected [1][6][8]. Summary of Fundraising Situation - The company raised a total of approximately 1.1 billion yuan (1,104,583,864.98 yuan) from its initial public offering, with a net amount of approximately 1.02 billion yuan (1,023,334,385.36 yuan) after deducting issuance costs [1][3]. - The excess funds amount to approximately 359.38 million yuan (359,378,285.36 yuan) [3][7]. Investment Project Situation - The company has outlined specific investment projects in its prospectus, with a total investment of approximately 663.96 million yuan (66,395.61 thousand yuan) [2][3]. Previous Use of Excess Funds - The company has previously used excess funds for share repurchase, with a plan to buy back shares at a price not exceeding 30 yuan per share, with a total repurchase amount between 10 million yuan and 20 million yuan [3][4]. - As of July 15, 2024, the company repurchased 921,322 shares, accounting for 0.22% of the total share capital [4]. Plan for Using Excess Funds - The company intends to use 100 million yuan (100,000,000 yuan) of the excess funds for permanent working capital, which represents 27.83% of the total excess funds [7]. - The cumulative use of excess funds for working capital will not exceed 30% of the total excess funds within the last 12 months [7]. Related Commitments and Explanations - The use of excess funds for working capital will not affect the funding needs of investment projects and complies with relevant regulations [6][8]. - The company commits to not engaging in high-risk investments or providing financial assistance to entities outside its controlling subsidiaries within 12 months after using the funds for working capital [7][8]. Review Procedures - The proposal to use part of the excess funds for working capital has been approved by the company's board of directors and supervisory board, and will be submitted for shareholder approval [6][8].